|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
decreases activity multiple interactions |
ISO |
morin results in decreased activity of ABCB11 protein morin inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid] |
CTD |
PMID:24014644 |
|
NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases activity multiple interactions |
ISO |
morin results in increased activity of ABCB1 protein morin promotes the reaction [Quercetin results in increased activity of ABCB1 protein] |
CTD |
PMID:34217736 |
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
decreases activity |
ISO |
morin results in decreased activity of ABCC1 protein |
CTD |
PMID:15670588 |
|
NCBI chr10:1,022,041...1,162,431
Ensembl chr10:531,812...655,114
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions |
EXP |
morin inhibits the reaction [Ifosfamide results in increased activity of ACHE protein] |
CTD |
PMID:31722249 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions |
EXP |
morin inhibits the reaction [Dimethylnitrosamine results in increased expression of ACTA2 mRNA]; morin inhibits the reaction [Dimethylnitrosamine results in increased expression of ACTA2 protein] |
CTD |
PMID:18629640 |
|
NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
multiple interactions |
EXP |
morin analog inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of ADIPOQ protein] |
CTD |
PMID:24854284 |
|
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
AHR gene mutant form inhibits the reaction [morin results in increased expression of CYP1A1 mRNA]; AHR gene mutant form inhibits the reaction [morin results in increased expression of UGT1A1 mRNA] |
CTD |
PMID:29584932 |
|
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
multiple interactions |
EXP |
morin inhibits the reaction [Excitatory Amino Acid Agonists affects the localization of AIFM1 protein] |
CTD |
PMID:19201465 |
|
NCBI chr X:132,528,107...132,567,237
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions increases expression |
EXP ISO |
morin inhibits the reaction [Acetaminophen results in decreased phosphorylation of AKT1 protein]; morin inhibits the reaction [Excitatory Amino Acid Agonists results in decreased phosphorylation of AKT1 protein]; morin inhibits the reaction [Streptozocin results in increased expression of AKT1 mRNA] morin results in increased expression of AKT1 mRNA |
CTD |
PMID:19201465 PMID:26767949 PMID:28689916 PMID:35414346 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
increases expression |
ISO |
morin results in increased expression of APAF1 mRNA |
CTD |
PMID:28689916 |
|
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions |
ISO |
morin affects the reaction [APP protein binds to APP protein] |
CTD |
PMID:18537544 |
|
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Aqp2 |
aquaporin 2 |
multiple interactions |
EXP |
morin inhibits the reaction [Doxorubicin affects the expression of AQP2 protein] |
CTD |
PMID:31100273 |
|
NCBI chr 7:132,590,286...132,595,321
Ensembl chr 7:130,711,413...130,716,468
|
|
G |
Ar |
androgen receptor |
decreases expression multiple interactions |
ISO EXP |
morin results in decreased expression of AR mRNA morin inhibits the reaction [[bisphenol S co-treated with diethyl phthalate] results in increased expression of AR mRNA] |
CTD |
PMID:24726691 PMID:35900689 |
|
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
EXP ISO |
morin inhibits the reaction [[bisphenol S co-treated with diethyl phthalate] results in increased expression of BAX mRNA]; morin inhibits the reaction [Acetaminophen results in increased expression of BAX protein]; morin inhibits the reaction [Diethylnitrosamine results in decreased expression of BAX protein]; morin inhibits the reaction [Doxorubicin affects the expression of BAX protein]; morin inhibits the reaction [Excitatory Amino Acid Agonists results in increased expression of BAX protein]; morin inhibits the reaction [Streptozocin results in increased expression of BAX mRNA]; morin inhibits the reaction [titanium dioxide results in increased expression of BAX mRNA] morin results in increased expression of BAX mRNA |
CTD |
PMID:19201465 PMID:19931519 PMID:26767949 PMID:28689916 PMID:28844848 PMID:31100273 PMID:35414346 PMID:35900689 More...
|
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bche |
butyrylcholinesterase |
multiple interactions |
EXP |
morin inhibits the reaction [Ifosfamide results in increased activity of BCHE protein] |
CTD |
PMID:31722249 |
|
NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:158,307,584...158,401,148
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
EXP ISO |
morin inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein]; morin inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 protein]; morin inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]; morin inhibits the reaction [Ifosfamide results in decreased expression of BCL2 mRNA]; morin inhibits the reaction [Streptozocin results in increased expression of BCL2 mRNA]; morin inhibits the reaction [titanium dioxide results in decreased expression of BCL2 mRNA] morin results in decreased expression of BCL2 mRNA |
CTD |
PMID:19931519 PMID:26767949 PMID:28689916 PMID:28844848 PMID:31100273 PMID:31722249 PMID:35414346 More...
|
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
decreases expression multiple interactions |
ISO EXP |
morin results in decreased expression of BCL2L1 mRNA morin inhibits the reaction [Streptozocin results in increased expression of BCL2L1 mRNA] |
CTD |
PMID:28689916 PMID:35414346 |
|
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions |
EXP |
morin inhibits the reaction [Ifosfamide results in increased expression of BDNF mRNA]; morin inhibits the reaction [Streptozocin results in increased expression of BDNF mRNA] |
CTD |
PMID:31722249 PMID:35414346 |
|
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
decreases expression |
ISO |
morin results in decreased expression of BIRC2 mRNA |
CTD |
PMID:28689916 |
|
NCBI chr 8:13,253,697...13,273,672
Ensembl chr 8:4,968,842...4,988,732
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
decreases expression |
ISO |
morin results in decreased expression of BIRC3 mRNA |
CTD |
PMID:28689916 |
|
NCBI chr 8:13,285,702...13,313,329
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
decreases expression |
ISO |
morin results in decreased expression of BIRC5 mRNA |
CTD |
PMID:28689916 |
|
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity |
EXP ISO |
morin inhibits the reaction [Acetaminophen results in increased activity of CASP3 protein]; morin inhibits the reaction [Acetaminophen results in increased cleavage of CASP3 protein]; morin inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP3 protein]; morin inhibits the reaction [Ifosfamide results in increased activity of CASP3 protein]; morin inhibits the reaction [Streptozocin results in increased expression of CASP3 mRNA]; morin inhibits the reaction [titanium dioxide results in increased expression of CASP3 mRNA] morin results in increased activity of CASP3 protein |
CTD |
PMID:19931519 PMID:24726691 PMID:26767949 PMID:28844848 PMID:31722249 PMID:35414346 More...
|
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
increases activity |
ISO |
morin results in increased activity of CASP7 protein |
CTD |
PMID:24726691 |
|
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
EXP |
morin inhibits the reaction [Acetaminophen results in increased activity of CASP9 protein]; morin inhibits the reaction [Diethylnitrosamine results in decreased expression of CASP9 protein] |
CTD |
PMID:19931519 PMID:26767949 |
|
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions |
EXP |
Indomethacin promotes the reaction [morin inhibits the reaction [Freund's Adjuvant results in decreased activity of CAT protein]]; morin analog inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased activity of CAT protein]; morin inhibits the reaction [[bisphenol S co-treated with diethyl phthalate] results in decreased activity of CAT protein]; morin inhibits the reaction [Acetaminophen results in decreased activity of CAT protein]; morin inhibits the reaction [Doxorubicin results in decreased activity of CAT protein]; morin inhibits the reaction [Excitatory Amino Acid Agonists results in decreased activity of CAT protein]; morin inhibits the reaction [Freund's Adjuvant results in decreased activity of CAT protein]; morin inhibits the reaction [Ifosfamide results in decreased activity of CAT protein]; morin inhibits the reaction [Streptozocin results in decreased activity of CAT protein]; morin promotes the reaction [Indomethacin inhibits the reaction [Freund's Adjuvant results in decreased activity of CAT protein]] |
CTD |
PMID:19201465 PMID:24854284 PMID:25698669 PMID:26767949 PMID:31100273 PMID:31722249 PMID:35414346 PMID:35900689 More...
|
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
EXP |
[morin co-treated with Indomethacin] inhibits the reaction [Freund's Adjuvant results in increased expression of CCL2 mRNA]; Indomethacin promotes the reaction [morin inhibits the reaction [Freund's Adjuvant results in increased expression of CCL2 protein]]; morin inhibits the reaction [Freund's Adjuvant results in increased expression of CCL2 mRNA]; morin inhibits the reaction [Freund's Adjuvant results in increased expression of CCL2 protein]; morin promotes the reaction [Indomethacin inhibits the reaction [Freund's Adjuvant results in increased expression of CCL2 protein]] |
CTD |
PMID:25698669 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
morin results in decreased expression of CCNB1 mRNA |
CTD |
PMID:28689916 |
|
NCBI chr 2:33,646,252...33,655,225
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Cdc25c |
cell division cycle 25C |
decreases expression |
ISO |
morin results in decreased expression of CDC25C mRNA |
CTD |
PMID:28689916 |
|
NCBI chr18:26,608,483...26,630,292
Ensembl chr18:26,335,834...26,356,185
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
decreases expression |
ISO |
morin results in decreased expression of CDK1 mRNA |
CTD |
PMID:28689916 |
|
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
ISO |
morin results in increased expression of CDKN1A mRNA |
CTD |
PMID:28689916 |
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Chek2 |
checkpoint kinase 2 |
decreases expression |
ISO |
morin results in decreased expression of CHEK2 mRNA |
CTD |
PMID:28689916 |
|
NCBI chr12:51,448,838...51,481,159
Ensembl chr12:45,788,827...45,821,286
|
|
G |
Col2a1 |
collagen type II alpha 1 chain |
multiple interactions |
ISO |
2-chloro-5-nitrobenzanilide inhibits the reaction [morin inhibits the reaction [COL2A1 protein results in increased expression of FASN mRNA]]; morin inhibits the reaction [COL2A1 protein results in increased expression of FASN mRNA] |
CTD |
PMID:36121554 |
|
NCBI chr 7:130,977,561...131,006,627
Ensembl chr 7:129,098,786...129,127,546
|
|
G |
Cp |
ceruloplasmin |
multiple interactions |
EXP |
[Indomethacin co-treated with morin] inhibits the reaction [Freund's Adjuvant results in increased expression of CP protein]; morin inhibits the reaction [Freund's Adjuvant results in increased expression of CP protein] |
CTD |
PMID:25698669 |
|
NCBI chr 2:104,368,336...104,427,119
Ensembl chr 2:102,439,624...102,498,075
|
|
G |
Ctsd |
cathepsin D |
multiple interactions |
EXP |
[morin co-treated with Indomethacin] inhibits the reaction [Freund's Adjuvant results in increased activity of CTSD protein]; morin inhibits the reaction [Freund's Adjuvant results in increased activity of CTSD protein] |
CTD |
PMID:25698669 |
|
NCBI chr 1:206,956,945...206,968,821
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Cycs |
cytochrome c, somatic |
multiple interactions |
EXP |
morin inhibits the reaction [Diethylnitrosamine results in decreased expression of CYCS protein]; morin inhibits the reaction [Streptozocin results in increased expression of CYCS mRNA] |
CTD |
PMID:19931519 PMID:35414346 |
|
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases expression |
ISO |
morin affects the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA] AHR gene mutant form inhibits the reaction [morin results in increased expression of CYP1A1 mRNA] morin results in increased expression of CYP1A1 mRNA; morin results in increased expression of CYP1A1 protein |
CTD |
PMID:20930378 PMID:29584932 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Diablo |
diablo, IAP-binding mitochondrial protein |
increases expression |
ISO |
morin results in increased expression of DIABLO mRNA |
CTD |
PMID:28689916 |
|
NCBI chr12:38,716,668...38,731,285
Ensembl chr12:33,055,263...33,070,387
|
|
G |
Dio1 |
iodothyronine deiodinase 1 |
decreases activity |
ISO |
morin results in decreased activity of DIO1 protein |
CTD |
PMID:30561685 |
|
NCBI chr 5:127,303,089...127,319,784
Ensembl chr 5:122,074,279...122,090,970
|
|
G |
Dio3 |
iodothyronine deiodinase 3 |
decreases activity |
ISO |
morin results in decreased activity of DIO3 protein |
CTD |
PMID:30561685 |
|
NCBI chr 6:135,107,072...135,108,933
Ensembl chr 6:129,285,749...129,286,660
|
|
G |
Eif2a |
eukaryotic translation initiation factor 2A |
multiple interactions |
EXP |
[morin co-treated with 1,2-Dimethylhydrazine] results in increased phosphorylation of EIF2A protein |
CTD |
PMID:32028820 |
|
NCBI chr 2:144,911,247...144,944,705
Ensembl chr 2:142,761,416...142,795,068
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
multiple interactions increases phosphorylation |
EXP |
[1,2-Dimethylhydrazine co-treated with morin] results in increased expression of EIF2AK3 protein morin results in increased phosphorylation of EIF2AK3 protein |
CTD |
PMID:32028820 |
|
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Fadd |
Fas associated via death domain |
increases expression |
ISO |
morin results in increased expression of FADD mRNA |
CTD |
PMID:28689916 |
|
NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:199,739,994...199,745,653
|
|
G |
Fas |
Fas cell surface death receptor |
multiple interactions |
EXP |
morin inhibits the reaction [titanium dioxide results in increased expression of FAS mRNA] |
CTD |
PMID:28844848 |
|
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
increases expression |
ISO |
morin results in increased expression of FASLG mRNA |
CTD |
PMID:28689916 |
|
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fasn |
fatty acid synthase |
multiple interactions |
ISO |
2-chloro-5-nitrobenzanilide inhibits the reaction [morin inhibits the reaction [COL2A1 protein results in increased expression of FASN mRNA]]; morin inhibits the reaction [COL2A1 protein results in increased expression of FASN mRNA] |
CTD |
PMID:36121554 |
|
NCBI chr10:106,570,415...106,588,581
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
morin inhibits the reaction [Ifosfamide results in increased expression of FOS protein] |
CTD |
PMID:31722249 |
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
multiple interactions |
EXP |
morin inhibits the reaction [titanium dioxide results in increased expression of FSHB protein] |
CTD |
PMID:28844848 |
|
NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
Gfap |
glial fibrillary acidic protein |
multiple interactions |
EXP |
morin inhibits the reaction [Ifosfamide results in increased expression of GFAP protein] |
CTD |
PMID:31722249 |
|
NCBI chr10:88,352,987...88,361,661
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
EXP |
morin analog inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased activity of GPT protein]; morin inhibits the reaction [Doxorubicin results in increased activity of GPT protein] |
CTD |
PMID:24854284 PMID:31100273 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
multiple interactions |
EXP |
morin inhibits the reaction [[bisphenol S co-treated with diethyl phthalate] results in decreased activity of GPX1 protein] |
CTD |
PMID:35900689 |
|
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
multiple interactions |
EXP |
[1,2-Dimethylhydrazine co-treated with morin] results in increased expression of GPX2 mRNA |
CTD |
PMID:32028820 |
|
NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:95,493,589...95,496,877
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
multiple interactions |
EXP |
morin inhibits the reaction [Acetaminophen results in decreased phosphorylation of GSK3B protein]; morin inhibits the reaction [Diethylnitrosamine results in increased expression of GSK3B protein modified form] |
CTD |
PMID:19931519 PMID:26767949 |
|
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
EXP |
morin inhibits the reaction [Streptozocin results in decreased activity of GSR protein] |
CTD |
PMID:35414346 |
|
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
EXP |
[1,2-Dimethylhydrazine co-treated with morin] results in increased expression of HMOX1 mRNA; morin inhibits the reaction [Acetaminophen results in decreased expression of HMOX1 protein] |
CTD |
PMID:26767949 PMID:32028820 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
morin inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased abundance of Nitric Oxide] |
CTD |
PMID:22698256 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
EXP |
morin inhibits the reaction [[bisphenol S co-treated with diethyl phthalate] results in decreased expression of IL10 mRNA] |
CTD |
PMID:35900689 |
|
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il17a |
interleukin 17A |
multiple interactions |
EXP |
[morin co-treated with Indomethacin] inhibits the reaction [Freund's Adjuvant results in increased expression of IL17A mRNA]; morin inhibits the reaction [Freund's Adjuvant results in increased expression of IL17A mRNA] |
CTD |
PMID:25698669 |
|
NCBI chr 9:30,640,844...30,644,331
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO EXP |
morin inhibits the reaction [[Lipopolysaccharides co-treated with Thioglycolates] results in increased expression of IL1B mRNA]; morin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] [morin co-treated with Indomethacin] inhibits the reaction [Freund's Adjuvant results in increased expression of IL1B mRNA]; Indomethacin promotes the reaction [morin inhibits the reaction [Freund's Adjuvant results in increased expression of IL1B protein]]; morin inhibits the reaction [[bisphenol S co-treated with diethyl phthalate] results in increased expression of IL1B mRNA]; morin inhibits the reaction [Doxorubicin results in increased expression of IL1B protein]; morin inhibits the reaction [Freund's Adjuvant results in increased expression of IL1B mRNA]; morin inhibits the reaction [Freund's Adjuvant results in increased expression of IL1B protein]; morin promotes the reaction [Indomethacin inhibits the reaction [Freund's Adjuvant results in increased expression of IL1B protein]] |
CTD |
PMID:22698256 PMID:25698669 PMID:31100273 PMID:35900689 |
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO EXP |
morin inhibits the reaction [[Lipopolysaccharides co-treated with Thioglycolates] results in increased expression of IL6 mRNA]; morin inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA] [morin co-treated with Indomethacin] inhibits the reaction [Freund's Adjuvant results in increased expression of IL6 mRNA]; morin inhibits the reaction [Freund's Adjuvant results in increased expression of IL6 mRNA] |
CTD |
PMID:22698256 PMID:25698669 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ins1 |
insulin 1 |
multiple interactions |
EXP |
morin analog inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of INS1 protein]; morin inhibits the reaction [Streptozocin results in decreased expression of INS1 protein] |
CTD |
PMID:24854284 PMID:35414346 |
|
NCBI chr 1:261,186,119...261,186,686
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Iyd |
iodotyrosine deiodinase |
multiple interactions |
ISO |
morin inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine] |
CTD |
PMID:33352258 |
|
NCBI chr 1:42,410,099...42,425,414
Ensembl chr 1:40,004,041...40,019,319
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
[morin co-treated with Indomethacin] inhibits the reaction [Freund's Adjuvant results in increased expression of JUN mRNA]; morin inhibits the reaction [Freund's Adjuvant results in increased expression of JUN mRNA] |
CTD |
PMID:25698669 |
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Kit |
KIT proto-oncogene receptor tyrosine kinase |
multiple interactions |
EXP |
morin inhibits the reaction [titanium dioxide results in decreased expression of KIT mRNA] |
CTD |
PMID:28844848 |
|
NCBI chr14:32,901,615...32,978,895
Ensembl chr14:32,548,877...32,624,652
|
|
G |
Krt1 |
keratin 1 |
multiple interactions |
ISO |
morin inhibits the reaction [Calcium results in increased expression of KRT1 mRNA] |
CTD |
PMID:12069687 |
|
NCBI chr 7:134,855,311...134,860,537
Ensembl chr 7:132,976,620...132,981,844
|
|
G |
Lep |
leptin |
multiple interactions |
EXP |
morin analog inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of LEP protein] |
CTD |
PMID:24854284 |
|
NCBI chr 4:58,626,529...58,640,663
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lhb |
luteinizing hormone subunit beta |
multiple interactions |
EXP |
morin inhibits the reaction [titanium dioxide results in increased expression of LHB protein] |
CTD |
PMID:28844848 |
|
NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
EXP |
morin inhibits the reaction [Excitatory Amino Acid Agonists results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:19201465 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
EXP |
morin inhibits the reaction [Excitatory Amino Acid Agonists results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:19201465 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
EXP |
morin inhibits the reaction [Ifosfamide results in increased activity of MAPK8 protein] |
CTD |
PMID:31722249 |
|
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mgst1 |
microsomal glutathione S-transferase 1 |
multiple interactions |
EXP |
[1,2-Dimethylhydrazine co-treated with morin] results in increased expression of MGST1 mRNA |
CTD |
PMID:32028820 |
|
NCBI chr 4:172,760,930...172,776,157
Ensembl chr 4:171,029,630...171,044,892
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions |
EXP |
morin inhibits the reaction [Diethylnitrosamine results in increased expression of MMP2 protein] |
CTD |
PMID:19539802 |
|
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression |
EXP ISO |
morin inhibits the reaction [Diethylnitrosamine results in increased expression of MMP9 protein] morin results in decreased expression of MMP9 mRNA |
CTD |
PMID:16304905 PMID:19539802 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
increases expression |
ISO |
morin results in increased expression of MTOR mRNA |
CTD |
PMID:28689916 |
|
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
EXP |
[1,2-Dimethylhydrazine co-treated with morin] affects the localization of NFE2L2 protein; morin inhibits the reaction [Acetaminophen results in decreased expression of and affects the localization of NFE2L2 protein]; morin inhibits the reaction [Acetaminophen results in increased ubiquitination of and results in decreased expression of NFE2L2 protein]; morin inhibits the reaction [Ifosfamide results in decreased expression of NFE2L2 protein] |
CTD |
PMID:26767949 PMID:31722249 PMID:32028820 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nos1 |
nitric oxide synthase 1 |
multiple interactions |
EXP |
morin inhibits the reaction [Ifosfamide results in increased activity of NOS1 protein] |
CTD |
PMID:31722249 |
|
NCBI chr12:44,276,011...44,456,371
Ensembl chr12:38,626,714...38,710,945
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO EXP |
morin inhibits the reaction [[Lipopolysaccharides co-treated with Thioglycolates] results in increased expression of NOS2 mRNA] [morin co-treated with Indomethacin] inhibits the reaction [Freund's Adjuvant results in increased expression of NOS2 mRNA]; morin inhibits the reaction [Freund's Adjuvant results in increased expression of NOS2 mRNA] |
CTD |
PMID:22698256 PMID:25698669 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nphs1 |
NPHS1 adhesion molecule, nephrin |
multiple interactions |
EXP |
morin inhibits the reaction [Doxorubicin affects the expression of NPHS1 protein] |
CTD |
PMID:31100273 |
|
NCBI chr 1:94,848,261...94,876,522
Ensembl chr 1:85,720,812...85,749,078
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
EXP |
morin inhibits the reaction [Acetaminophen results in decreased activity of NQO1 protein]; morin inhibits the reaction [Acetaminophen results in decreased expression of NQO1 protein] Morin enhances the reaction [Carbon tetrachloride increases expression of Nqo1 mRNA in liver] |
CTD RGD |
PMID:26767949 PMID:29307993 |
RGD:25823195 |
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Ntrk2 |
neurotrophic receptor tyrosine kinase 2 |
multiple interactions |
EXP |
morin inhibits the reaction [Streptozocin results in increased expression of NTRK2 mRNA] |
CTD |
PMID:35414346 |
|
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,559,043...5,869,136
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases expression |
ISO |
morin results in increased expression of PARP1 mRNA |
CTD |
PMID:28689916 |
|
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pde5a |
phosphodiesterase 5A |
multiple interactions |
EXP |
morin inhibits the reaction [[bisphenol S co-treated with diethyl phthalate] results in increased activity of PDE5A protein] |
CTD |
PMID:35900689 |
|
NCBI chr 2:213,542,822...213,687,638
Ensembl chr 2:210,858,063...210,999,701
|
|
G |
Pdk1 |
pyruvate dehydrogenase kinase 1 |
multiple interactions |
EXP |
morin inhibits the reaction [Diethylnitrosamine results in increased expression of PDK1 protein modified form] |
CTD |
PMID:19931519 |
|
NCBI chr 3:77,113,464...77,144,145
Ensembl chr 3:56,705,871...56,733,038
|
|
G |
Phlpp2 |
PH domain and leucine rich repeat protein phosphatase 2 |
multiple interactions |
EXP |
morin inhibits the reaction [Acetaminophen results in increased expression of PHLPP2 protein] |
CTD |
PMID:26767949 |
|
NCBI chr19:54,744,581...54,811,258
Ensembl chr19:37,835,125...37,905,513
|
|
G |
Pik3cb |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta |
increases expression |
ISO |
morin results in increased expression of PIK3CB mRNA |
CTD |
PMID:28689916 |
|
NCBI chr 8:108,474,017...108,579,140
Ensembl chr 8:99,594,644...99,699,663
|
|
G |
Plau |
plasminogen activator, urokinase |
decreases expression |
ISO |
morin results in decreased expression of PLAU protein |
CTD |
PMID:38093596 |
|
NCBI chr15:3,505,485...3,511,987
Ensembl chr15:3,456,232...3,462,775
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
affects localization multiple interactions affects binding |
ISO |
morin affects the localization of PPARG protein 2-chloro-5-nitrobenzanilide inhibits the reaction [morin promotes the reaction [PPARG protein binds to SP1 protein]]; morin promotes the reaction [PPARG protein binds to SP1 protein] morin binds to PPARG protein |
CTD |
PMID:36121554 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Prkab1 |
protein kinase AMP-activated non-catalytic subunit beta 1 |
decreases expression |
ISO |
morin results in decreased expression of PRKAB1 mRNA |
CTD |
PMID:28689916 |
|
NCBI chr12:46,248,971...46,259,487
Ensembl chr12:40,588,211...40,598,661
|
|
G |
Prkce |
protein kinase C, epsilon |
decreases expression |
ISO |
morin results in decreased expression of PRKCE mRNA |
CTD |
PMID:28689916 |
|
NCBI chr 6:13,718,050...14,204,931
Ensembl chr 6:7,965,048...8,451,719
|
|
G |
Pten |
phosphatase and tensin homolog |
multiple interactions |
EXP |
morin inhibits the reaction [Diethylnitrosamine results in decreased expression of PTEN protein modified form] |
CTD |
PMID:19931519 |
|
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP |
[morin co-treated with Indomethacin] inhibits the reaction [Freund's Adjuvant results in increased expression of PTGS2 mRNA]; Indomethacin promotes the reaction [morin inhibits the reaction [Freund's Adjuvant results in increased expression of PTGS2 protein]]; morin inhibits the reaction [Diethylnitrosamine results in increased expression of PTGS2 mRNA]; morin inhibits the reaction [Diethylnitrosamine results in increased expression of PTGS2 protein]; morin inhibits the reaction [Freund's Adjuvant results in increased expression of PTGS2 mRNA]; morin inhibits the reaction [Freund's Adjuvant results in increased expression of PTGS2 protein]; morin promotes the reaction [Indomethacin inhibits the reaction [Freund's Adjuvant results in increased expression of PTGS2 protein]] |
CTD |
PMID:19539802 PMID:25698669 |
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptpn1 |
protein tyrosine phosphatase, non-receptor type 1 |
decreases activity |
ISO |
morin results in decreased activity of PTPN1 protein |
CTD |
PMID:29175190 |
|
NCBI chr 3:177,056,588...177,106,424
Ensembl chr 3:156,638,769...156,687,504
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
[morin co-treated with Indomethacin] inhibits the reaction [Freund's Adjuvant results in increased expression of RELA mRNA]; Indomethacin promotes the reaction [morin inhibits the reaction [Freund's Adjuvant results in increased expression of RELA protein]]; morin inhibits the reaction [[bisphenol S co-treated with diethyl phthalate] results in increased expression of RELA protein]; morin inhibits the reaction [Diethylnitrosamine results in increased expression of RELA mRNA]; morin inhibits the reaction [Diethylnitrosamine results in increased expression of RELA protein]; morin inhibits the reaction [Diethylnitrosamine results in increased localization of RELA protein]; morin inhibits the reaction [Excitatory Amino Acid Agonists affects the localization of and results in increased activity of RELA protein]; morin inhibits the reaction [Freund's Adjuvant results in increased expression of RELA mRNA]; morin inhibits the reaction [Freund's Adjuvant results in increased expression of RELA protein]; morin promotes the reaction [Indomethacin inhibits the reaction [Freund's Adjuvant results in increased expression of RELA protein]] |
CTD |
PMID:19201465 PMID:19539802 PMID:25698669 PMID:35900689 |
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
increases expression |
ISO |
morin results in increased expression of RPS6KB1 mRNA |
CTD |
PMID:28689916 |
|
NCBI chr10:71,817,794...71,865,211
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Slc16a1 |
solute carrier family 16 member 1 |
multiple interactions |
ISO EXP |
morin inhibits the reaction [SLC16A1 protein results in increased uptake of Benzoic Acid] [morin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate |
CTD |
PMID:17108059 PMID:17976262 |
|
NCBI chr 2:194,805,556...194,832,966
Ensembl chr 2:192,124,289...192,144,611
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions |
EXP |
morin inhibits the reaction [[bisphenol S co-treated with diethyl phthalate] results in decreased activity of SOD1 protein] |
CTD |
PMID:35900689 |
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sp1 |
Sp1 transcription factor |
multiple interactions |
ISO |
2-chloro-5-nitrobenzanilide inhibits the reaction [morin promotes the reaction [PPARG protein binds to SP1 protein]]; morin promotes the reaction [PPARG protein binds to SP1 protein] |
CTD |
PMID:36121554 |
|
NCBI chr 7:135,419,864...135,450,513
Ensembl chr 7:133,541,491...133,571,961
|
|
G |
Star |
steroidogenic acute regulatory protein |
multiple interactions |
EXP |
morin inhibits the reaction [titanium dioxide results in decreased expression of STAR mRNA] |
CTD |
PMID:28844848 |
|
NCBI chr16:72,969,824...72,974,447
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
decreases phosphorylation |
ISO |
morin results in decreased phosphorylation of STAT3 protein |
CTD |
PMID:38093596 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
EXP |
morin inhibits the reaction [Dimethylnitrosamine results in increased expression of TGFB1 mRNA]; morin inhibits the reaction [Dimethylnitrosamine results in increased expression of TGFB1 protein] |
CTD |
PMID:18629640 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO EXP |
morin inhibits the reaction [[Lipopolysaccharides co-treated with Thioglycolates] results in increased expression of TNF mRNA]; morin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; morin inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] [Indomethacin co-treated with morin] inhibits the reaction [Freund's Adjuvant results in increased expression of TNF mRNA]; Indomethacin promotes the reaction [morin inhibits the reaction [Freund's Adjuvant results in increased expression of TNF protein]]; morin analog inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of TNF protein]; morin inhibits the reaction [[bisphenol S co-treated with diethyl phthalate] results in increased expression of TNF mRNA]; morin inhibits the reaction [Doxorubicin results in increased expression of TNF protein]; morin inhibits the reaction [Freund's Adjuvant results in increased expression of TNF mRNA]; morin inhibits the reaction [Freund's Adjuvant results in increased expression of TNF protein]; morin inhibits the reaction [Ifosfamide results in increased expression of TNF protein]; morin inhibits the reaction [titanium dioxide results in increased expression of TNF protein]; morin promotes the reaction [Indomethacin inhibits the reaction [Freund's Adjuvant results in increased expression of TNF protein]] |
CTD |
PMID:22698256 PMID:24854284 PMID:25698669 PMID:28844848 PMID:31100273 PMID:31722249 PMID:35900689 More...
|
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf25 |
TNF receptor superfamily member 25 |
increases expression |
ISO |
morin results in increased expression of TNFRSF25 mRNA |
CTD |
PMID:28689916 |
|
NCBI chr 5:162,621,669...162,626,341
Ensembl chr 5:162,622,075...162,626,341
|
|
G |
Tnfsf11 |
TNF superfamily member 11 |
multiple interactions |
EXP |
[morin co-treated with Indomethacin] inhibits the reaction [Freund's Adjuvant results in increased expression of TNFSF11 mRNA]; morin inhibits the reaction [Freund's Adjuvant results in increased expression of TNFSF11 mRNA] |
CTD |
PMID:25698669 |
|
NCBI chr15:60,083,008...60,114,479
Ensembl chr15:53,673,877...53,705,445
|
|
G |
Tp53 |
tumor protein p53 |
increases expression multiple interactions |
ISO EXP |
morin results in increased expression of TP53 mRNA morin inhibits the reaction [Ifosfamide results in increased expression of TP53 protein] |
CTD |
PMID:28689916 PMID:31722249 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
multiple interactions |
EXP |
[1,2-Dimethylhydrazine co-treated with morin] results in increased expression of TXNRD1 mRNA |
CTD |
PMID:32028820 |
|
NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
increases glucuronidation multiple interactions decreases activity |
ISO |
UGT1A1 protein results in increased glucuronidation of morin AHR gene mutant form inhibits the reaction [morin results in increased expression of UGT1A1 mRNA] morin results in decreased activity of UGT1A1 protein |
CTD |
PMID:14557274 PMID:29584932 PMID:35063619 |
|
NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a2 |
UDP glucuronosyltransferase 1 family, polypeptide A2 |
decreases activity |
ISO |
morin results in decreased activity of UGT1A3 protein |
CTD |
PMID:35063619 |
|
NCBI chr 9:96,239,019...96,256,264
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a3 |
UDP glycosyltransferase 1 family, polypeptide A3 |
multiple interactions |
EXP |
[1,2-Dimethylhydrazine co-treated with morin] results in increased expression of UGT1A5 mRNA |
CTD |
PMID:32028820 |
|
NCBI chr 9:96,228,134...96,256,264
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a6 |
UDP glucuronosyltransferase family 1 member A6 |
decreases activity |
ISO |
morin results in decreased activity of UGT1A6 protein |
CTD |
PMID:35063619 |
|
NCBI chr 9:96,195,018...96,256,264
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
increases glucuronidation decreases activity |
ISO |
UGT1A9 protein results in increased glucuronidation of morin morin results in decreased activity of UGT1A9 protein |
CTD |
PMID:14557274 PMID:35063619 |
|
NCBI chr 9:96,144,786...96,256,264
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt2b7 |
UDP glucuronosyltransferase family 2 member B7 |
decreases activity |
ISO |
morin results in decreased activity of UGT2B7 protein |
CTD |
PMID:35063619 |
|
NCBI chr14:21,251,535...21,274,451
Ensembl chr14:20,896,682...20,919,604
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
EXP |
Indomethacin promotes the reaction [morin inhibits the reaction [Freund's Adjuvant results in increased expression of VEGFA protein]]; morin inhibits the reaction [[bisphenol S co-treated with diethyl phthalate] results in increased expression of VEGFA mRNA]; morin inhibits the reaction [Freund's Adjuvant results in increased expression of VEGFA protein]; morin promotes the reaction [Indomethacin inhibits the reaction [Freund's Adjuvant results in increased expression of VEGFA protein]] |
CTD |
PMID:25698669 PMID:35900689 |
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Wee1 |
WEE1 G2 checkpoint kinase |
increases expression |
ISO |
morin results in increased expression of WEE1 mRNA |
CTD |
PMID:28689916 |
|
NCBI chr 1:173,605,609...173,632,450
Ensembl chr 1:164,174,779...164,197,688
|
|